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doi:10.1016/j.ejvs.2010.12.015Abstract Objectives: To gain insight into early mechanisms of aortic widening, we examined
associations between the diameter of the abdominal aorta (AD) and cardiovascular disease
(CVD) risk factors and biomarkers, as well as measures of subclinical atherosclerosis, in a mul-
ti-ethnic population.
Design: Cross-sectional cohort.
Methods: A total of 1926 participants (mean age 62, 50% women) underwent chest and
abdomen scanning by computed tomography, ultrasound of the carotid arteries, and CVD risk
factor assessment. AD was measured 5 cm above and at the bifurcation.
Results: In a model containing traditional CVD risk factors, biomarkers and ethnicity, only age
(standardized b Z 0.97), male sex (b Z 1.88), body surface area (standardized b Z 0.92),
current smoking (bZ 0.42), D-dimer levels (bZ 0.19) and hypertension (bZ 0.53) were inde-
pendently and significantly associated with increasing AD (in mm) at the bifurcation; use of
cholesterol-lowering medications predicted smaller AD (b Z 0.70) (P < 0.01 for all). These
findings were similar for AD 5 cm above the bifurcation with one exception: compared to Cau-
casianeAmericans, Americans of Chinese, African and Hispanic descent had significantly smal-
ler AD 5 cm above the bifurcation (b0sZ 0.59, 0.49, and 0.52, respectively, all P < 0.01),
whereas AD at the bifurcation did not differ by ethnicity. Physical activity, alcohol consump-
tion, diabetes and levels of IL-6, CRP and homocysteine were not independently associated
with AD. Higher aortic and coronary artery calcium burden, but not common carotid artery
intima-media thickness, were independently, but modestly (bZ 0.11 to 0.19), associated with
larger AD.822 2416; fax: þ1 858 534 0377.
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There is controversy as to whether the predominant etiology
of abdominal aortic aneurysm (AAA) is arteriosclerosis (the
process leading to muscular thickening of the arterial wall)1
or atherosclerosis (deposition of lipid into and accompanied
by inflammation of the intima-media complex).1,2 For
instance, traditional risk factors are differentially associ-
ated with AAA compared to CHD3 and aortic diameter (AD) is
inconsistently related to aortic calcification.4e6 Studies
attempting to discern which process is dominant are difficult
since there is an overlap in the risk factors for these two
conditions. Some have concluded that risk factors for
occlusive arterial disease such as hypertension and lipids
may not be associated with AAA.7,8
Studies that allow for more sensitive detection of
atherosclerosis in the extracoronary vasculature and its
association with abdominal AD, an early marker of aneu-
rysmal development, provide the opportunity to expand
the current literature on this issue. The Multi-Ethnic Study
of Atherosclerosis (MESA) provides a unique opportunity to
do so in a population of younger adults without AAA, while
considering potential ethnic differences. To gain insight
into the mechanisms underlying widening of the aortic
diameter, we examined the magnitude and significance of
the associations of abdominal AD at, and 5 cm above, the
bifurcation with coronary and aortic calcification, carotid
atherosclerosis, as well as CVD risk factors and biomarkers.
Methods
Study participants
The Multi-Ethnic Study of Atherosclerosis (MESA) is
a prospective cohort study investigating subclinical
atherosclerosis in 6814 individuals aged 45e84 years who
were free of clinically manifest CVD at baseline.9 Partici-
pants of non-Hispanic white, ChineseeAmerican, Afri-
caneAmerican, or HispaniceAmerican origin were
originally recruited between July 2000 and August 2002
from 6 U.S. field centers.
This report includes the random sample of MESA subjects
who participated in the MESA Abdominal Aortic Calcium
Study (MESAeAACS). MESAeACCS participants were
recruited during follow-up visits between August 2002 and
September 2005 from 5 MESA field centers: Chicago, IL;
Forsyth County, NC; Los Angeles County, CA; New York, New
York; and St. Paul, MN. Of 2202 MESA subjects recruited,
2172 agreed to participate, and 1968 satisfied MESAeACCS
eligibility criteria including age and ethnicity subsampling
from the MESA, postmenopausal status, and no recent
diagnostic abdominal computed tomography (CT). This
study includes the 970 men and 956 postmenopausal
women who had AD data available at the four anatomiclocations of interest. Signed informed consent was obtained
for all participants, and institutional review board approval
was obtained from all participating institutions.
Risk factor assessment
Standardized questionnaires at the baseline MESA exami-
nation were used to obtain participant information on
demographics, current prescription medication usage,
medical history, smoking history, alcohol consumption, and
physical activity. Body mass index (BMI) was calculated as
weight in kilograms divided by height in meters squared;
body surface area (BSA) as 0.20247  (height
(m0.725))  (weight (kg0.425)). Blood pressure was measured
three times in the seated position with a Dinamap model
Pro 100 automated oscillometric sphygmomanometer, and
the average of the last 2 measurements was used.
Blood samples obtained after a 12-h fast were used for
measurement of total cholesterol, high density lipoprotein
(HDL) cholesterol, triglycerides, glucose, C-reactive protein
(CRP), interleukin-6 (IL-6), fibrinogen, D-dimer, factor VIII
and homocysteine by previously described methods.10
Hypertension was defined as systolic blood pressure
140 mm Hg, diastolic blood pressure 90 mm Hg or
current use of anti-hypertensive medication. Diabetes was
defined as fasting plasma glucose >126 mg/dL, reported
physician diagnosis of diabetes, or use of hypoglycemic
medications. Individuals with a total to HDL cholesterol
ratio >5 or who reported use of a medication to treat high
cholesterol were classified as dyslipidemic.
CT scanning
Participants underwent CT scanning of the chest and
abdomen to ascertain the presence and extent of coronary
artery calcium and abdominal aorta calcium. Coronary
scans were performed in duplicate for accuracy with
cardiac-gated electron-beam scanners at 3 field centers
(Imatron C-150; Imatron, Inc., San Francisco, California) or
with a prospectively electrocardiogram-triggered scan
acquisition at 50% of the RR interval with multidetector
scanners at the remaining 3 centers (New York, Forsyth
County, and St. Paul field centers). Details of the MESA CT
scanning and quality assurance procedures have been
reported.11
Image analysis for calcium
Scans were read centrally by the MESA CT Reading Center at
the Los Angeles Biomedical Research Institute (Torrance,
California). After scanning, images were reconstructed in
a 35-cm field of view with 5-mm slice thickness. All scan
scores were brightness adjusted with a standard phantom.
Calcium was scored in an 8-cm segment of the distal
abdominal aorta ending at the aortic bifurcation.
Table 1 Characteristics of the study population.
Characteristic Value (N Z 1926)
Age, mean (SD) years 62.1 (9.8)
BMI, mean (SD) kg/m2 28.1 (5.1)
BSA, mean (SD) m2 1.87 (0.23)
Female Sex, No. (%) 956 (49.6)
Ethnicity, No. (%)
Caucasian 775 (40.2)
ChineseeAmerican 254 (13.2)
AfricaneAmerican 405 (21.0)
HispaniceAmerican 492 (25.5)
Smoker Former, No. (%) 704 (36.6)
Smoker Current, No. (%) 247 (12.8)
Alcohol Former, No. (%) 434 (22.6)
Alcohol Current, No. (%) 1090 (56.8)
Physical activity, Mets/wk 3454 (3902)
Dyslipidemia, No. (%) 676 (35.1)
Hypertension, No. (%) 874 (45.4)
Diabetes Mellitus, No. (%) 218 (11.4)
Family History CHD, No. (%) 779 (43.5)
Calcium, No. (%>0)
Coronary 969 (50.3)
Descending aorta 1377 (71.5)
Carotid intima-media thickness
CCA, median (IQR) mm 0.85 (0.24)
CHD, coronary heart disease.
IQR, interquartile range.
CCA, common carotid artery.
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a density of >130 HU and quantified using the Agatston
scoring method.12
Image analysis for aortic diameter
Images from the abdominal CT scans were retrospectively
interrogated to determine the diameter of the abdominal
aorta using computer software (Osiris 4.19, University of
Geneva, Geneva, Switzerland). Measures were conducted
at 5 cm proximal to the aortic bifurcation and at the slice
just above the aortic bifurcation. An adjustable-size elec-
tronic caliper in the shape of a circle was used to measure
the diameter (d ) by fitting the caliper around the circum-
ference (C ) of the adventitia of the aorta. The computer
then calculated the diameter from the circumference
measurement using the equation, d Z C/p. Each location
was measured three times by a single reader who was
unaware of subject characteristics; the average of these
measurements was used in the analysis; the intraclass
correlation was 0.93, average difference between
measurements was 4.0%.
Carotid ultrasonography
Images of the right and left common carotid arteries (CCA)
were captured, including images of the near and far walls,
by trained personnel using high-resolution B-mode ultra-
sound.A Logiq 700 ultrasound machine (GE Medical
Systems, Waukesha, Wisconsin) was used at all centers. All
studies were recorded on optical disk and super VHS
videotape and sent weekly to a central ultrasound reading
center located at Tufts Medical Center, Tufts University.
The high-resolution images of the CCAs were analyzed to
calculate near- and far-wall IMT, lumen diameter, and
vessel width at each arterial site using a specially designed
computer program.13 Intima-media thickness (IMT) of the
CCA was defined as the mean of all available maximum wall
thicknesses across both left and right sides.
Statistical analysis
Descriptive statistics of the study cohort were summarized
by means, medians, or frequencies as appropriate. Analysis
of covariance was used to calculate the adjustedmean value
or prevalence of the subject characteristics by sex-specific
quartile of AD. Multivariable linear regression was used to
determine the simultaneous significance of associations
between AD and the CVD risk factors, as well as the presence
and extent of atherosclerosis in distinct vascular beds. The
vascular calcium variables were normalized by trans-
formation using log10 of (calcium score þ1). Multivariable
linear regression results are presented per sex-specific
standard deviation (SD) increase in each vascular calcium
and IMT measurement. There was no significant collinearity
(conservatively defined as variance inflation factor >5 or
tolerance <0.2). Following the recommendation of Roth-
man,14 no adjustment was made for multiple comparisons;
rather exact P-values for two-sided tests are shown; P 0.05
was considered statistically significant. Analyses were con-
ducted using SPSSv15 (SPSS Inc., Chicago, IL).Results
Characteristics of the 1926 participants (49.6% women) are
presented in Table 1. The men and women ranged in age
from 44 to 84 years; 41% were classified as overweight and
31% as obese. The median calcium scores in the coronary
arteries and abdominal aortic artery were 0 and 235,
respectively, and the median CCA IMT was 0.85 mm; 50.3%
had any coronary artery calcium, 71.5% had abdominal
aortic artery calcium. The mean (SD) aortic diameter (AD)
was 18.8 (3.0) mm at 5 cm proximal to the aortic bifurca-
tion and 19.0 (3.0) mm just above the aortic bifurcation. AD
was significantly larger (P < 0.001) in men than women
at both sites independent of age, BSA (or height) and
ethnicity.
Mean age- and sex-adjusted values for traditional CVD
risk factors, biomarkers and measures of subclinical
atherosclerosis by quartile of AD are shown in Table 2.
There were significant linear trends for increasing age, BMI,
BSA, height and smoking and alcohol consumption preva-
lence across AD quartiles at each site (P < 0.01 for all).
Abdominal AD was not related to lipid levels or to the
prevalence of dyslipidemia or diabetes. Blood pressure
measures increased linearly with AD at the bifurcation
(P  0.01), with less robust associations for AD 5 cm above
the bifurcation. Levels of IL-6, CRP and D-dimer were
positively related to AD at both sites (P < 0.01 for all).
Homocysteine and fibrinogen associations were only
Table 2 Population characteristics by sex-specific regional AD quartile.
AD site: 5 cm above bifurcation Bifurcation P value
Q1 Q2 Q3 Q4 P value Q1 Q2 Q3 Q4
Range women (mm) (12e16) (17e17) (18e18) (19e30) (11e16) (17e17) (18e19) (20e33)
Range men (mm) (13e18) (19e19) (20e21) (22e41) (13e18) (19e19) (20e21) (22e38)
Sample size 594 381 487 464 593 327 569 437
Characteristic
Age, yrs 59.8 60.8 62.3 65.9 <0.01 58.9 60.5 62.7 66.7 <0.01
BMI, kg/m2 26.8 27.9 28.6 29.6 <0.01 26.5 27.6 28.5 30.2 <0.01
BSA, m2 1.79 1.84 1.90 1.96 <0.01 1.78 1.85 1.90 1.97 <0.01
Height, cm 164.2 165.4 168.3 170.0 <0.01 164.4 166.3 167.9 169.4 <0.01
Smoker past, % 33.0 31.8 38.1 43.5 <0.01 35.1 35.6 37.5 38.1 0.73
Smoker current, % 8.9 10.3 14.3 18.5 <0.01 10.6 11.9 13.0 16.3 0.07
Alcohol past, % 23.4 21.2 20.8 24.8 0.65 23.6 21.7 19.9 25.5 0.66
Alcohol current, % 48.8 58.1 60.6 61.2 <0.01 52.6 54.2 59.1 60.4 <0.01
Physical activity,
Mets/wk
3461 3492 3287 3591 0.78 3381 3558 3434 3502 0.73
TC/HDL ratio 4.12 4.12 4.08 4.14 0.85 4.15 4.04 4.13 4.14 0.78
Dyslipidemia, % 35.7 37.0 35.0 32.5 0.24 37.7 35.4 35.3 30.8 0.04
Lipid-lowering
med use, %
18.3 16.7 15.7 13.1 0.08 17.2 18.0 17.0 11.8 0.06
Diabetes mellitus, % 11.9 11.4 11.1 10.8 0.57 10.5 10.4 12.6 11.7 0.40
SBP, mmHg 125.9 127.6 126.6 127.8 0.23 126.1 125.8 126.1 129.9 <0.01
DBP, mmHg 71.5 72.7 72.7 73.4 <0.01 71.3 71.4 72.3 75.1 <0.01
Hypertension, % 43.5 42.1 44.1 51.6 <0.01 40.9 38.6 45.3 56.5 <0.01
CRP, mg/L 1.71 1.64 1.98 2.29 <0.01 1.71 1.88 1.87 2.19 <0.01
IL-6, pg/ml 1.11 1.14 1.19 1.35 <0.01 1.11 1.14 1.16 1.38 <0.01
D-dimer, mg/ml 0.20 0.23 0.21 0.24 <0.01 0.20 0.23 0.20 0.26 <0.01
Fibrinogen, g/L 3.37 3.35 3.34 3.40 0.46 3.34 3.33 3.36 3.43 0.05
Homocysteine,
mmol/L
8.85 8.85 8.88 9.12 0.08 9.0 8.68 8.8 9.28 0.05
Factor VIII, % 161.5 156.8 158.6 158.8 0.64 163.4 155.5 154.4 161.9 0.67
Family Hx CHD, % 39.3 43.7 43.4 49.1 <0.01 40.6 45.1 42.8 47.4 0.10
CCA IMT (mm) 0.858 0.864 0.869 0.891 <0.01 0.862 0.859 0.874 0.885 0.02
Calcium (>0), %
Coronary 47.3 51.2 47.6 56.1 0.01 46.2 51.9 51.2 53.4 0.03
Descending aorta 68.1 72.0 70.6 76.3 <0.01 67.9 72.0 73.1 73.8 0.03
Values are age- and sex-adjusted, P-values are for linear trend.
BSA, body surface area; TC, total cholesterol; Hx, history; SBP, systolic blood pressure; DBP, diastolic blood pressure.
CCA IMT, common carotid artery intima-media thickness.
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to AD. The prevalence of calcium in the abdominal aorta
and coronary arteries and IMT of the CCA increased across
quartiles of AD at each site (P < 0.05).
We next conducted multivariable linear regression anal-
ysis to determine which of the risk factors were indepen-
dently associated with AD (Table 3). Because the age- and
sex-adjusted correlation of BSA with AD was stronger than
that for BMI or height at both sites (respective partial
correlations 0.30, 0.16, and 0.27 with AD 5 cm above the
bifurcation and 0.35, 0.25, and 0.24 with AD at the bifur-
cation), BSA was used as a measure of body size for these
analyses. In the multivariate models, age, male sex, BSA,
and past and current smoking were independently associ-
ated with larger AD at both sites. Use of lipid-lowering
medications predicted smaller diameter at both sites(P< 0.01), whereas hypertension was associated with larger
AD only at the bifurcation. Compared to Caucasians, Afri-
caneAmericans and Hispanics had smaller AD on average
5 cm proximal to the bifurcation adjusting for all other
covariates; AD just above the bifurcation did not vary
significantly by ethnicity. The only biomarker independently
related to AD was D-dimer (P < 0.01). The multivariate
models explained 33 and 37% of the variance in AD, with sex,
age and BSA explaining 90% or more of this variance.
Fig. 1 presents results of multivariable linear regression
analyses for AD where the measure of subclinical athero-
sclerosis for each vascular bed was separately added to
a model containing all the risk factors from Table 3; it shows
the increment in AD attributable to the presence of each
subclinical measure. A 1-SD increase in aortic calcium score
was significantly (P < 0.01) associated with 0.16-mm larger
Table 3 Multivariable linear regression between tradi-
tional cardiovascular risk factors and AD.
Aortic site: 5 cm above
bifurcation
Bifurcation
Independent
variablea
bb P-value bb P-value
Age (10 yrs) 0.72 <0.01 0.97 <0.01
Sex (male vs female) 2.23 <0.01 1.88 <0.01
Ethnicity
(vs Caucasian)
Chinese-American 0.59 <0.01 0.14 0.43
African-American 0.49 <0.01 0.25 0.19
Hispanic 0.52 <0.01 0.13 0.30
Body surface
area (1 SD)
0.68 <0.01 0.92 <0.01
Diabetes
(yes vs no)
0.17 0.30 0.22 0.33
Hypertension
(yes vs no)
0.18 0.12 0.53 <0.01
Lipid-lowering meds
(yes vs no)
0.33 0.03 0.70 <0.01
Smoker former 0.39 <0.01 0.01 0.83
Smoker current 1.24 <0.01 0.42 0.03
Alcohol current 0.03 0.79 0.22 0.11
Physical activity
(1 SD)
0.01 0.83 0.02 0.83
CRP (1 SD) 0.01 0.87 0.12 0.08
IL-6 (1 SD) 0.02 0.82 0.08 0.26
D-dimer (1 SD) 0.17 <0.01 0.19 <0.01
Homocysteine
(1 SD)
0.05 0.37 0.05 0.44
MESA study site 0.02 0.52 0.03 0.43
Model R2 0.37 0.33
SD, sex-specific standard deviation.
a All variables in the same model.
b Linear regression coefficients; units are mm.
Figure 1 Results of linear regression analyses showing the
difference in aortic diameter 5 cm above the aortic bifurcation
(BIF) and just above the BIF per 1 SD increase in aortic artery
calcium score, coronary artery calcium score, and common
carotid artery intima-media thickness (CCA IMT). Values are
adjusted for age, sex, ethnicity, BSA, alcohol, smoking, dia-
betes, hypertension, D-dimer, and use of lipid-lowering medi-
cations; *indicates P < 0.01.
Aortic Diameter and Vascular Atherosclerosis 485AD 5 cm proximal to the bifurcation and non-significantly
(PZ .17) with 0.11 mm larger AD just above the bifurcation.
An SD increase in coronary calcium scores was associated
with 0.19-mm larger AD 5 cm proximal and just above the
bifurcation (P < 0.01 for both). IMT of the common carotid
artery was not associated with increased AD. These results
were not materially changed in models excluding the 22
individuals with AD 30 mm (data not shown).
Abdominal diameter was also assessed inferior to the
renal artery and 10 cm above the bifurcation. Notably,
multivariate associations with risk factors at both of these
sites were similar to those reported above including
significant associations of lipid-lowering medications and
non-Caucasian ethnicity with lower AD, and hypertension
and increasing aortic calcium with larger AD (all P < 0.01)
(data not shown).
Discussion
In this cross-sectional study of nearly 2000 MESA partici-
pants, the diameter of the abdominal aorta at four distinctlocations was significantly and positively associated with
age, male sex, body size, and smoking independent of
ethnicity and the other traditional cardiovascular risk
factors; use of lipid-lowering medications was associated
with smaller AD. Americans of Chinese, African and Hispanic
descent had smaller AD than CaucasianeAmericans 5 cm
above the birfurcation even after adjusting for differences in
body size and other covariates. Increments of aortic diam-
eter were modestly associated with measures of subclinical
atherosclerosis including calcified atherosclerosis in the
abdominal aorta and coronary arteries, independent of
associated risk factors. Taken together, these results suggest
a link between atherosclerotic risk factors, as well as
subclinical atherosclerotic disease, and enlargement of the
abdominal aortic diameter.
The primary positive predictors of AD in this study (age,
male sex and larger body size) agree with prior findings in
nearly 70,000 patients from 15 Veteran Affairs (VA) medical
centers15 and a study of 504 patients undergoing whole
body CT.16 The 2e3 mm sex difference in aortic diameter in
the MESA cohort was comparable to earlier reports,16e18
and persisted after adjusting for larger male body size
and other covariates. Unlike the studies above, we also
found significant increments in AD associated with smoking
and hypertension that were not explained by the other risk
factors. The relative risk of aneurysm in current smokers is
at least three times that of non-smokers19 and smoking
constitutes a significant risk factor for aneurysm enlarge-
ment.20 If risk factors for larger AD are similar to those for
AAA, our results suggest that smoking may be involved early
in the pathogenesis of aneurysm formation. In most prior
studies, hypertension had only a weak or no association
with AAA.21 We found a moderately strong positive associ-
ation of hypertension with AD at the bifurcation, despite
the fact that 71% of individuals classified as hypertensive
were taking anti-hypertensive medications, which might be
expected to reduce any association.
Inverse correlates of AD have also been identified in the
literature. The presence of diabetes was inversely related
to the diameter of the abdominal aorta in three
studies.16,21,22 In the present study, AD did not vary by
486 G.A. Laughlin et al.diabetes, dyslipidemia, cholesterol, or the total to HDL
cholesterol ratio at any of the four aortic segments exam-
ined. However, use of lipid-lowering medications, 95% of
which were statins, was a strong independent predictor of
smaller AD; the reduction in AD associated with statin use
was equivalent to more than a 5 year reduction in age.
Possible explanations for statin benefit may include
suppression of matrix metalloproteinase (MMP), down
regulation of proinflammatory gene expression, and pres-
ervation of medial elastin and smooth muscle cells.23,24
Moreover, there is some clinical evidence that statin
therapy improves prognosis for individuals with small AAA.
In two observational studies including 280 AAA patients
followed for 2e3 years, the pooled growth rate was 3 mm
less per year in those who were taking statins compared
with those not taking statins.25
To our knowledge, this is the first population-based study
of the epidemiology of aortic diameter to include a large
proportion of ethnic minorities. In the VA study by Lederle et
al.,15 black race was associated with a small (0.1 mm), but
significant, increase in infrarenal AD. This contrasts with our
finding of 0.4e0.5 mm smaller AD in AfricaneAmericans
compared to Caucasians at three of the four aortic segments
studied. We tested whether this difference might be due to
the fact that the VA population was almost exclusively (97%)
male. In analyses stratified by sex, AD was significantly
smaller among both male and female AfricaneAmericans in
MESA compared to their Caucasian counterparts. The lower
AD observed in Chinese and Hispanic Americans is in linewith
reports of a much lower prevalence of AAA among British
citizens of Asian descent compared to Caucasians26,27 and
fewer surgical procedures to repair aortic aneurysms in
Hispanics than Caucasians.28,29 These ethnic differences
provide additional evidence that AAA disproportionately
affects Caucasians. That they are independent of body size
aswell as novel and traditional CVD risk factors suggest a role
for either unmeasured or ethnicity-related genetic factors in
determining AD.
Of the six cardiovascular biomarkers considered in this
analysis, only D-dimer levels were associated with aortic
diameter independent of the major risk factors. Levels of
D-dimer are higher in individuals with small30 and large31,32
abdominal aneurysms and are thought to be a result of the
release of fibrin degradation products during continual
remodeling of intraluminal thrombus,33 a key pathological
element in aneurysmal expansion. Higher D-dimer levels in
individuals with larger AD are evidence of increased fibri-
nolytic activity and implicates chronic fibrin turnover early
in the pathogenesis of AAA.
Some limitations of the present study should be noted.
Gomes and colleagues have shown that CT is a valid method
to evaluate AD and is more accurate than ultrasonog-
raphy.34 Nonetheless, there is a small probability of
residual error in the measurement of AD by EBCT scanners
due to motion artifact, although mechanisms aimed at
reducing this error were employed and the aorta moves
little compared to the coronaries. Another limitation is the
absence of data on family history of AAA, a major AAA risk
factor.3,22 This study is also limited by the nature of the
population. Participation in MESA was restricted to indi-
viduals who were free of clinically manifest CVD at base-
line. Thus, this sample may not be fully generalizable to thegeneral population which includes persons with known
atherosclerotic disease.
An unresolved question is the extent to which aortic
aneurysms are a manifestation of atherosclerosis or a result
of distinct pathogenic processes. Although 31e90% of
patients with established AAA are reported to have coro-
nary artery disease,35 the fact that the prevalence of aortic
aneurysm has not changed or is even increasing at the same
time that incidence and mortality rates from coronary
artery disease are decreasing36,37 argues against a common
pathway. So does the much stronger relative risk of current
smoking for AAA (3e6-fold) compared to CHD (1e2-fold)19
and the inverse association of diabetes with diagnosed
AAA in some studies.38 The positive association of AD with
subclinical atherosclerotic calcification observed in this and
a prior study16 adds to the evidence that dilatation of the
AD may be another component of systemic vascular
disease, but it does not prove an etiologic role for athero-
sclerotic processes. In our study, incremental widening of
the AD shared some, but not all, risk factors for occlusive
vascular disease, and much of the variance in AD remained
unexplained. Thus, while this study provides additional
evidence that the pathophysiology of aortic aneurysms may
depend in part on atherosclerotic processes, other mech-
anisms seem likely.
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